Coppersmith Presentation to Alere Inc Stockholders
PAGE 62 |
Alere's Nominees: Redundant Experience & Questionable Judgment
Brian Markison
COPPERSMITH
▪ Mr. Markison was Chairman, President & CEO of King Pharmaceuticals until March, 2011
> We believe Mr. Markison's pharmaceutical background to be redundant in context of the other nominees and are
concerned by his close ties to fellow Company nominee Dr. Håkan Björklund (whom we do not oppose)
> The Company's proxy discloses that both Dr. Björklund and Mr. Markison are currently operating partners of private
equity firm Avista Capital Partners
> The Company's proxy also notes that Dr. Björklund was CEO of Nycomed Luxco SA and Mr. Markison was CEO of
Fougera Pharmaceuticals, Inc.
> What the proxy does not disclose is that Fougera was previously known as Nycomed US Inc., a spin-off of Nycomed
Nor does Alere's proxy disclose the fact that Dr. Björklund was Chairman of Nycomed US and hired Mr. Markison 40
Håkan Björklund
▪ Dr. Björklund was CEO of Nycomed Luxco SA, a pharmaceutical company, until September 2011
> Coppersmith does not oppose the election of Dr. BjörklundView entire presentation